References
Vos T, Flaxman AD, Naghavi M, et al. (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study. The Lancet 380(9859):2163–2196
Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19:703–711
Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Steiner TJ (2014) Headache-attributed burden and its impact on productivity and quality of life in Russia: structured healthcare for headache is urgently needed. Eur J Neurol 21:758–765
Acknowledgements
The current study was part of the Value of Treatment Project coordinated by the European Brain Council. The value of treatment of headache was supported by Novartis AG and Teva Pharmaceuticals.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Leonardi, M., Ruiz De La Torre, E., Steiner, T.J. et al. Value of treatment of headache patients and need to improve headache patients’ journey. Neurol Sci 39 (Suppl 1), 115–116 (2018). https://doi.org/10.1007/s10072-018-3366-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-018-3366-6